New tool aims to make opioid tapering safer and less scary

NCT ID NCT07202026

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Kaiser Permanente Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to create a decision aid to help patients on long-term opioid therapy and their doctors have better conversations about safely reducing or stopping opioids. Researchers will interview patients and doctors to understand their experiences, then test the tool with 30 patients. The goal is to reduce fear, improve trust, and avoid harms like untreated pain or relapse to illicit opioids.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Patient-centered Decision Aid (behavioral intervention)
What this could lead to: If successful, this could lead to a tool that helps patients and doctors have better conversations about safely reducing opioid use, potentially reducing harm from forced tapering.
What could go wrong: This is a small pilot study with only 30 participants, so results may not apply to everyone. The decision aid may not work as well in real-world settings or for diverse populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID TAPERING

Contacts and locations

Locations

Kaiser Permanente Washington Health Research Institute

Seattle, Washington, 98101, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.